Subcellular targeting regulates the function of caspase-activated protein kinases in apoptosis

Drug Resistance Updates

Volumn 7, Issue 1, 2004, Pages 11-17

  Jakobi, Rolf ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Cancer therapy; Caspase activated protein kinases; Subcellular localization

Indexed keywords

CASPASE; CASPASE ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MST1 PROTEIN; P21 ACTIVATED KINASE 2; PROTEIN KINASE C; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN TARGETING; PROTEIN TRANSPORT; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 1842555274     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2004.01.001     Document Type: Article

References (58)

1. Abo, A., Qu, J., Cammarano, M.S., Dan, C., Fritsch, A., Baud, V., Belisle, B., Minden, A., 1998. PAK4 a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 17, 6527-6540.
2. Bagrodia, S., Cerione, R.A., 1999. Pak to the future. Trends Cell Biol. 9, 350-355.
3. Bagrodia, S., Taylor, S.J., Creasy, C.L., Chernoff, J., Cerione, R.A., 1995. Identification of a mouse p21Cdc42/Rac activated kinase. J. Biol. Chem. 270, 22731-22737.
4. Bokoch, G.M., 2003. Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743-781.
5. Cardone, M.H., Salvesen, G.S., Widmann, C., Johnson, G., Frisch, S.M., 1997. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90, 315-323.
6. Chan, W.H., Yu, J.S., Yang, S.D., 1998. Heat shock stress induces cleavage and activation of PAK2 in apoptotic cells. J. Protein Chem. 17, 485-494.
7. Chen, S., Yin, X., Zhu, X., Yan, J., Ji, S., Chen, C., Cai, M., Zhang, S., Zong, H., Hu, Y., Yuan, Z., Shen, Z., Gu, J., 2003. The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis. J. Biol. Chem. 278, 20029-20036.
8. Cheng, J.Q., Jiang, X., Fraser, M., 2002. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase pathway. Drug Resist. Update 5, 131-146.
9. Cheung, W.L., Ajiro, K., Samejima, K., Kloc, M., Cheung, P., Mizzen, C.A., Beeser, A., Etkin, L.D., Chernoff, J., Earnshaw, W.C., Allis, C.D., 2003. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113, 507-517.
10. Creasy, C.L., Chernoff, J., 1995. Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. Gene 167, 303-306.
11. Creasy, C.L., Ambrose, D.M., Chernoff, J., 1996. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J. Biol. Chem. 271, 21049-21053.
12. Datta, R., Kojima, H., Yoshida, K., Kufe, D., 1997. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272, 20317-20320.
13. Desagher, S., Martinou, J.C., 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377.
14. Emoto, Y., Manome, Y., Meinhardt, G., et al., 1995. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J. 14, 6148-6156.
15. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., Nagata, S., 1998. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391, 43-50.
16. Fanger, G.R., Johnson, N.L., Johnson, G.L., 1997. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J. 16, 4961-4972.
17. Fanger, G.R., Widmann, C., Porter, A.C., Sather, S., Johnson, G.L., Vaillancourt, R.R., 1998. 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 273, 3476-3483.
18. Gnesutta, N., Qu, J., Minden, A., 2001. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414-14419.
19. Graves, J.D., Gotoh, Y., Draves, K.E., Ambrose, D., Han, D.K., Wright, M., Chernoff, J., Clark, E.A., Krebs, E.G., 1998. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17, 2224-2234.
20. Graves, J.D., Draves, K.E., Gotoh, Y., Krebs, E.G., Clark, E.A., 2001. Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J. Biol. Chem. 276, 14909-14915.
21. Green, D.R., 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102, 1-4.
22. Jakobi, R., Chen, C.J., Tuazon, P.T., Traugh, J.A., 1996. Molecular cloning and sequencing of the cytostatic G protein-activated protein kinase PAK I. J. Biol. Chem. 271, 6206-6211.
23. Jakobi, R., Huang, Z., Walter, B.N., Tuazon, P.T., Traugh, J.A., 2000. Substrates enhance autophosphorylation and activation of p21-activated protein kinase γ-PAK in the absence of activation loop phosphorylation. Eur. J. Biochem. 267, 4414-4421.
24. Jakobi, R., Moertl, E., Koeppel, M.A., 2001. p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276, 16624-16634.
25. Jakobi, R., McCarthy, C.C., Koeppel, M.A., Stringer, D.K., 2003. Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J. Biol. Chem. 278, 38675-38685.
26. Knaus, U.G., Bokoch, G.M., 1998. The p21Rac/Cdc42-activated kinases (PAKs). Int. J. Biochem. Cell Biol. 30, 857-862.
27. Knaus, U.G., Morris, S., Dong, H.J., Chernoff, J., Bokoch, G.M., 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269, 221-223.
28. Lee, N., MacDonald, H., Reinhard, C., Halenbeck, R., Roulston, A., Shi, T., Williams, L.T., 1997. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 13642-13647.
29. Lei, M., Lu, W., Meng, W., Parrini, M.C., Eck, M.J., Mayer, B.J., Harrison, S.C., 2000. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102, 387-397.
30. Lin, Y., Khokhlatchev, A., Figeys, D., Avruch, J., 2002. Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. J. Biol. Chem. 277, 47991-48001.
31. WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy. Drug Resist. Update 6, 183-195.
32. Lu, Z., Xu, S., Joazeiro, C., Cobb, M.H., Hunter, T., 2002. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 9, 945-956.
33. Manser, E., Leung, T., Salihuddin, H., Zhao, Z.S., Lim, L., 1994. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46.
34. Manser, E., Chong, C., Zhao, Z.S., Leung, T., Michael, G., Hall, C., Lim, L., 1995. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J. Biol. Chem. 270, 25070-25078.
35. Martin, G.A., Bollag, G., McCormick, F., Abo, A., 1995. A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J. 14, 1970-1978.
36. Mira, J.P., Benard, V., Groffen, J., Sanders, L.C., Knaus, U.G., 2000. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 185-189.
37. Roig, J., Traugh, J.A., 2001. Cytostatic p21 G protein-activated protein kinase γ-PAK. Vitam. Horm. 62, 167-198.
38. Rudel, T., Bokoch, G.M., 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574.
39. Rudel, T., Zenke, F.T., Chuang, T.H., Bokoch, G.M., 1998. p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J. Immunol. 160, 7-11.
40. Russell, M., Lange-Carter, C.A., Johnson, G.L., 1995. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J. Biol. Chem. 270, 11757-11760.
41. Sabourin, L.A., Tamai, K., Seale, P., Wagner, J., Rudnicki, M.A., 2000. Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region. Mol. Cell. Biol. 20, 684-696.
42. Sawada, M., Sun, W., Hayes, P., Leskov, K., Boothman, D.A., Matsuyama, S., 2003. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol. 5, 320-329.
43. Schlesinger, T.K., Bonvin, C., Jarpe, M.B., Fanger, G.R., Cardinaux, J.-R., Johnson, G.L., Widmann, C., 2002. Apoptosis stimulated by the 91-kDa caspase cleavage MEKK1 fragment requires translocation to soluble cellular compartments. J. Biol. Chem. 277, 10283-10291.
44. Schurmann, A., Mooney, A.F., Sanders, L.C., Sells, M.A., Wang, H.G., Reed, J.C., Bokoch, G.M., 2000. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 20, 453-461.
45. Sells, M.A., Chernoff, J., 1997. Emerging from the Pak: the p21-activated protein kinase family. Trends Cell Biol. 7, 162-167.
46. Shibata, M., Hattori, H., Sasaki, T., Gotoh, J., Hamada, J., Fukuuchi, Y., 2002. Subcellular localization of a promoter and an inhibitor of apoptosis (Smac/DIABLO and XIAP) during brain ischemia/reperfusion. Neuroreport 13, 1985-1988.
47. Tang, T.K., Chang, W.C., Chan, W.H., Yang, S.D., Ni, M.H., Yu, J.S., 1998. Proteolytic cleavage and activation of PAK2 during UV irradiation-induced apoptosis in A431 cells. J. Cell. Biochem. 70, 442-454.
48. Tang, Y., Zhou, H., Chen, A., Pittman, R.N., Field, J., 2000. The akt proto-oncogene links ras to pak and cell survival signals. J. Biol. Chem. 275, 9106-9109.
49. Teo, M., Manser, E., Lim, L., 1995. Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J. Biol. Chem. 270, 26690-26697.
50. Ura, S., Masuyama, N., Graves, J.D., Gotoh, Y., 2001. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc. Natl. Acad. Sci. U.S.A. 98, 10148-10153.
51. Vasilevskaya, I., O'Dwyer, P.J., 2003. Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist. Update 6, 147-156.
52. Walter, B.N., Huang, Z., Jakobi, R., Tuazon, P.T., Alnemri, E.S., Litwack, G., Traugh, J.A., 1998. Cleavage and activation of p21-activated protein kinase γ-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. J. Biol. Chem. 273, 28733-28739.
53. West, K.A., Castillo, S.S., Dennis, P.A., 2002. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist. Update 5, 234-248.
54. Widmann, C., Johnson, N.L., Gardner, A.M., Smith, R.J., Johnson, G.L., 1997. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1. Oncogene 15, 2439-2447.
55. Widmann, C., Gerwins, P., Johnson, N.L., Jarpe, M.B., Johnson, G.L., 1998. MEK kinase 1, a substrate for DEVD-directed caspases is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18, 2416-2429.
56. Witowsky, J.A., Johnson, G.L., 2003. Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J. Biol. Chem. 278, 1403-1406.
57. Yang, F., Li, X., Sharma, M., Zarnegar, M., Lim, B., Sun, Z., 2001. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J. Biol. Chem. 25, 15345-15353.
58. Yujiri, T., Sather, S., Fanger, G.R., Johnson, G.L., 1998. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282, 1911-1914.